Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > [9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:?), (9R,9′R)-rel-

[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:?), (9R,9′R)-rel-

[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:?), (9R,9′R)-rel- structure

[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:?), (9R,9′R)-rel- 

structure
  • CAS No:

    52730-36-6

  • Formula:

    C42H38O20.xCa

  • Chemical Name:

    [9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:?), (9R,9′R)-rel-

  • Synonyms:

    [9,9′-Bianthracene]-2,2′-dicarboxylic acid,5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-,calcium salt (1:?),(9R,9′R)-rel-;[9,9′-Bianthracene]-2,2′-dicarboxylic acid,5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-,calcium salt,(R*,R*)-;[9,9′-Bianthracene]-2,2′-dicarboxylic acid,5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-,calcium salt,(9R,9′R)-;Sennoside A calcium salt

  • Categories:

    Biochemical Engineering  >  Saccharides

Description

Medications derived from SENNA EXTRACT that are used to treat CONSTIPATION.

[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:?), (9R,9′R)-rel- Basic Attributes

900.80100

900.1425844

263-461-9|258-140-5|258-141-0

0ZS912W56A

Characteristics

353.62000

-3.76500

1144.8ºC at 760 mmHg

348.6ºC

Safety Information

|Danger|H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]|P261, P272, P280, P285, P302+P352, P304+P341, P321, P333+P313, P342+P311, P363, and P501|Aggregated GHS information provided by 78 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION. (See all compounds classified as Laxatives.)

Pursennid

Computed Properties

Molecular Weight:900.8
Hydrogen Bond Donor Count:10
Hydrogen Bond Acceptor Count:20
Rotatable Bond Count:9
Exact Mass:900.1425844
Monoisotopic Mass:900.1425844
Topological Polar Surface Area:354
Heavy Atom Count:63
Complexity:1550
Defined Atom Stereocenter Count:12
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Guide of [9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:?), (9R,9′R)-rel-

Request for Quotation

Share

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.